Testing effectiveness (Phase 2)Ended earlyNCT04335071
What this trial is testing
Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
Who this might be right for
SARS-CoV-2 Infection
Insel Gruppe AG, University Hospital Bern 5
Showing 20 of 0 results